microdosing glp-1 for autoimmune Why Microdosing? A Closer Look at Reported Benefits GLP-1 Genetics: How Genes Affect

GLP-1 is rapidly degraded by DPP-4 under normal circumstances

In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures

GLP-1 Plus appears in the conversation as part of this emerging pattern not as a stand-alone phenomenon, but as one participant in the broader evolution of how people define and pursue well-being in the modern era

Efficacy is on par with injectable semaglutide with up to 1.7% reduction on the highest dose, and change in fasting glucose from -30 to -42mg/dl which is a significant improvement in glycemia

[DOI] [PMC free article] [PubMed] [Google Scholar] 81.Manna P., Jain S.K

In fact, protein is the most satiating macronutrient